Hepatitis E Virus (HEV) Antibodies, IgG and IgM
Also known as: HEV PAN
Use
This test is used for the detection of IgG and IgM antibodies against the Hepatitis E virus. The presence of IgG antibodies indicates exposure to the virus, whereas the presence of IgM antibodies suggests an active or recent infection. This test aids in the evaluation of acute and past Hepatitis E virus infection.
Special Instructions
Not provided.
Limitations
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. The test is performed in a CLIA-certified laboratory and is intended for clinical purposes. Results should be interpreted in the context of the patient's clinical presentation and other diagnostic tests.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
Hepatitis E Virus Ab, IgG
ProteinHepatitis E Virus Ab, IgM
Protein
LOINC Codes
- 14211-7 - HEV IgG Ser Ql
- 14212-5 - HEV IgM Ser Ql
- 58936-6 - HEV Ab Ser Ql IA
Result Turnaround Time
1-5 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
0.5 mL
Minimum Volume
0.3 mL
Container
Serum separator tube (SST). Also acceptable: lavender (K2 EDTA), lavender (K3 EDTA), or pink (K2EDTA).
Collection Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer to an ARUP Standard Transport Tube.
Storage Instructions
Refrigerated.
Causes for Rejection
Specimens containing particulate material.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | 2 weeks |
| Frozen | Indefinitely (avoid repeated freeze/thaw cycles) |
Other tests from different labs that may be relevant